Anna Misiachna

Specific pathogenic mutations in the M3 domain of the GluN1 subunit regulate the surface delivery and pharmacological sensitivity of NMDA receptors

Marharyta Kolcheva, Štěpán Kortus, Barbora Hrčka Krausová et al. · Neuropharmacology · 2021 · 23 citations

Glun1 Subunit, Signal Transduction, M3 Domain +9

Structure-activity relationships of dually-acting acetylcholinesterase inhibitors derived from tacrine on N-methyl-d-Aspartate receptors

Lukáš Górecki, Anna Misiachna, Rafael Doležal et al. · European Journal of Medicinal Chemistry · 2021 · 19 citations · Full text

The pathogenic N650K variant in the GluN1 subunit regulates the trafficking, conductance, and pharmacological properties of NMDA receptors

Marharyta Kolcheva, Marek Ladislav, Jakub Netolický et al. · Neuropharmacology · 2022 · 16 citations · Full text

Pursuing the Complexity of Alzheimer’s Disease: Discovery of Fluoren-9-Amines as Selective Butyrylcholinesterase Inhibitors and N-Methyl-d-Aspartate Receptor Antagonists

Jan Konečný, Anna Misiachna, Martina Hrabinová et al. · Biomolecules · 2020 · 13 citations · Full text

Morphing cholinesterase inhibitor amiridine into multipotent drugs for the treatment of Alzheimer's disease

Eva Mezeiová, Lukáš Prchal, Martina Hrabinová et al. · Biomedicine & Pharmacotherapy · 2024 · 12 citations · Full text